» Articles » PMID: 24859456

TERT Promoter Mutations: Gatekeeper and Driver of Hepatocellular Carcinoma

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2014 May 27
PMID 24859456
Citations 26
Authors
Affiliations
Soon will be listed here.
Citing Articles

Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.

Zheng L, Wang Y, Liu Z, Wang Z, Tao C, Wu A Cancer Med. 2024; 13(7):e7043.

PMID: 38572921 PMC: 10993708. DOI: 10.1002/cam4.7043.


Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets.

Pessino G, Scotti C, Maggi M, Immuno-Hub Consortium Cancers (Basel). 2024; 16(5).

PMID: 38473265 PMC: 10931414. DOI: 10.3390/cancers16050901.


Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology.

Coffin P, He A Int J Mol Sci. 2023; 24(17).

PMID: 37686079 PMC: 10487618. DOI: 10.3390/ijms241713274.


Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center.

Maloberti T, De Leo A, Sanza V, Gruppioni E, Altimari A, Riefolo M World J Gastroenterol. 2022; 28(25):2854-2866.

PMID: 35978866 PMC: 9280731. DOI: 10.3748/wjg.v28.i25.2854.


Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma.

Kotiyal S, Evason K Cancers (Basel). 2021; 13(16).

PMID: 34439356 PMC: 8393605. DOI: 10.3390/cancers13164202.